News | October 31, 2023
Sun Pharma to co-market Zydus’s CKD treatment drug ‘Desidustat’ in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Subscribe To Our Newsletter & Stay Updated
